Cancer Commons’ most recent webinar, Testing Matters—Understanding Cancer Biomarker Testing and How It Applies to You, was held virtually on September 14, 2022. During the webinar, Cancer Commons Scientists Kaumudi Bhawe, PhD, and Adrienne Nugent, PhD, provided plain-language explanations of different types of biomarker testing and described why, how, when, and where to access testing. They also answered audience questions. The webinar was the… Read more »
Cancer Commons is excited to share our latest collaboration with the Pancreatic Cancer Action Network (PanCAN). The purpose of the grant-funded project is for Cancer Commons to help pancreatic cancer patients referred by PanCAN achieve their best possible treatment outcomes and enroll in a longitudinal study assessing individualized therapies and contributing to improved outcomes for future pancreatic cancer patients. Patients will be entered in… Read more »
We invite everyone to join an upcoming webinar focused on helping cancer patients and caregivers understand molecular testing, the strengths and limitations of each kind, and how testing can be used to understand and help with your or your loved one’s particular cancer. Testing Matters—Understanding Cancer Biomarker Testing and How It Applies to You, will be offered virtually and free of charge on September 14, 2022, at… Read more »
“Cancer really shook up our lives when I was young, but it also paved the way for my lifelong quest to be on the front lines of research, doing the work to understand cancer and help develop treatments from multiple angles.” —Kaumudi Bhawe, PhD Here at Cancer Commons, Scientist Kaumudi Bhawe, PhD, works one-on-one with cancer patients and caregivers to ensure they have the… Read more »
Cancer Commons/Musella Foundation study of combination treatment regimens aims to improve outcomes for patients, identify promising therapies for development.
Hear from our Clinical Scientist Kaumudi Bhawe, PhD, and CFO/COO Shelley Frisbie in the latest episode of “Wait How Do You Spell That?”—a podcast produced by the news site Patient Worthy. In this interview, they discuss why it is so important for every patient to receive expert, compassionate support that considers the uniqueness of their cancer case. Visit the episode website to listen.
Healthcare Executive Rebecca (Owens) Driscoll will lead Cancer Commons from July 1, 2022.
We invite everyone to join an upcoming educational webinar that will focus on challenges, strategies, and resources for loved ones of cancer patients—particularly those affected by advanced or metastatic cancer. You Are Not Alone—Validating the Caregiver Experience, will be offered virtually on May 18, 2022, at 12:00 PM PT / 3:00 PM ET. Many who reach out to Cancer Commons for help are among… Read more »
We invite everyone to join a March 2 webinar featuring Cancer Commons Chief Scientist Emma Shtivelman, PhD, in conversation with Cancer Commons Editor in Chief George Lundberg, MD. They will discuss cutting-edge options and trends in breast cancer treatment. The conversation offers an opportunity for cancer patients, survivors, caregivers, and medical professionals to understand the latest significant advancements in treating metastatic breast cancer, engage… Read more »
A virtual tumor board program launched at Cancer Commons in 2020 has shown preliminary promise in helping pancreatic cancer patients identify and access treatments, clinical trials, and diagnostic opportunities tailored to each patient’s individual case. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led evaluation of the initial success of the program, which is presented today at the American Society of Clinical… Read more »